SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy

SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy

Background: Non-alcoholic fatty liver disease (NAFLD) has a high prevalence in obesity and its presence should be screened. Laparoscopic sleeve gastrectomy (LSG) is an effective treatment for obesity, but its effects on NAFLD are still to be firmly established. The diagnosis of non-alcoholic steatoh...

Full description

Bibliographic Details
Main Authors: Silvia Bettini, Emanuel Bordigato, Gabriella Milan, Chiara Dal Pra’, Francesca Favaretto, Anna Belligoli, Marta Sanna, Roberto Serra, Mirto Foletto, Luca Prevedello, Luca Busetto, Giorgio Fassina, Roberto Vettor, Roberto Fabris
Format: Article
Language:English
Published: Karger Publishers 2019-05-01
Series:Obesity Facts
Subjects:
Obesity
Non-alcoholic fatty liver disease
SCCA-IgM
Prediabetes
Diabetes
Bariatric surgery
Online Access:https://www.karger.com/Article/FullText/499717

Internet

https://www.karger.com/Article/FullText/499717

Similar Items